O51267 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidnpzhfgyzuhjbdllbct7grbithcqvrtxhykgcoi6jln3xdgwbkci/metadata.json
IPFS of structure file: 
bafybeihcslruykrcjdynfw54dwg6askjbvhqeaubj774xhlgwznurf7tty/AF-O51267-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xee747bB73DB28d63168c8f1FC50610B9a0055D30
First NFT owner address (bech32): 
genesis1ae68hdeak2xkx95v3u0u2psshxsq2hfs3adxn6
Current NFT ID #449874 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449874
Accession (UniProt):
O51267
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Borreliella burgdorferi (strain ATCC 35210 / DSM 4680 / CIP 102532 / B31)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O51267 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O51267|SYL_BORBU Leucine--tRNA ligase OS=Borreliella burgdorferi (strain ATCC 35210 / DSM 4680 / CIP 102532 / B31) OX=224326 GN=leuS PE=3 SV=1 MSKYEFIKIEKKWQEFWDNNKTYKVEEDPSIPKEKRLYILDMFPYPSANGLHVGHPEGYTATDIFGRYKLLNGFHVLHPIGFDSFGLPAENYAIQTGTHPQKSTEENINKFKKQIKALGFAYDWDREIRTHEENYYKWTQWIFLQLYKKGLAYVKEMPVWYCPELGTVLANEEIIQTSDGPKSERGSYSVEKKYLRQWVLKITKYAERLLDDLEELEWPESVKEMQRNWIGKSTGVEIEFEIEGHSDKIKVFTTRPDTIFGITYLVIAPENKLIEKITKNNFKQNVLKYVKHEELKSDLNRTSLEKDKSGVFTGSYAFHPITNEKIPIWVGSYVLGTYGTGAVMGVPAHDERDFQFAKKYQLKILPVISKSGKNEILEKAFVDDGISINSPNEFNNLKNSEVKDKVIKWLTKNKKGKEKVAYKLRDWIFSRQRYWGEPIPILFDKLGNAIPLEENDLPLKLPEIANYKPSGTGESPLSRIKDWVNVKDMGFTRETNTMPQWAGSCWYYLRYLDPKNSKEFANKKKIEYWMPVDLYIGGAEHTVLHLLYSRFWHKVLYDLGYVNTKEPFKKLINQGIITSFSYQKENGVLIPNDQVIEKDNKFFDKKDNKEVTQVIAKMSKSLKNVINPDDIIKEFGADSMRIYEMFMGPLTDSKPWNTKGIIGVFRFLNKIWNLREKELSKENPPREIISELHKVIKKVTEDTEKLNFNTAISAMMIFINELLKYEKNYLNIFKPFIIILSPYAPHLAEELWEYIGELPSLFKNSKWPKFDESLIIKGKKEIVLQINGKIKDKILLNKETGEKELKEIAMENSKIKSNLLNKKIVKIIVIKNKLVNIVIK